SEOUL, SOUTH KOREA AND TAIPEI, TAIWAN - Media OutReach - 5 August 2020 - Kantar Health, a leading global healthcare data,analytics and research provider, today announces the expansion of its NationalHealth and Wellness Survey (NHWS) into South Korea and Taiwan. NHWS is the world's largest patient-reportedoutcomes survey and provides a unique patient perspective into health needs andexperiences.

Over 40,000 patients and caregivers in South Koreaand Taiwan will join the survey, increasing the global sample size to 250,000patients across 12 markets, which already include Japan and China. In its 23^rdyear of reporting, NHWS covers 200 medical conditions using validated researchinstruments and disease-specific measures.

NHWSalso has the flexibility to uncover timely, synergistic insights around globalhealthcare events through Pulse recontact surveys. The survey found that theproportion of patients reporting symptoms of moderate to severe depression inSouth Korea almost doubled from 16% to 30% since the start of the Covid-19pandemic. In comparison, the proportion ofrespondents reporting these symptoms in Taiwan, a country which has been widelypraised for its response to the pandemic, did not significantly change duringthe same period.

Lynnette Cooke, Global CEO, Kantar Health,commented, "Our goal is to understandpatients' unmet needs and provide guidance in the development of new therapiesto improve health outcomes and resource utilisation. The National Health andWellness Survey stands alone globally in providing robust evidence of theburden of illness that patients experience and the value that different medicalinterventions can deliver."

"With Patient-reported outcomes (PRO)increasingly being considered as part of regulatory submissions andreimbursement decisions in South Korea and Taiwan, we are delighted to addthese important countries to our global knowledge pool," added Questa Lin,General Manager, Taiwan, Kantar Health.

About Kantar Health

Kantar Health, adivision of Kantar, provides data, analytics and research to the life sciencesindustry. As real-world evidence and commercialization partners, Kantar Healthenables clients to bring safe and effective treatment to patients around theworld. The team has expertise across a myriad of therapy areas, includingunique thought leadership in oncology and rare diseases. For more informationon how to optimize commercial launch plans, demonstrate real-worldeffectiveness and safety, and build ongoing value substantiation to unlock yourfull potential, visit www.kantar.com/expertise/health. Kantar helps clientsunderstand people and inspire growth.